Intensity Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Intensity Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) (NCT06263231) | Intensity Therapeutics, Inc. | 2024-06-28 |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (NCT03058289) | Intensity Therapeutics, Inc. | 2017-02-09 |
Track Intensity Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.